Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.

Nearly a year after alarms about CAR T-cell therapies possibly causing secondary lymphomas, studies suggest that genetic predisposition—not vector integration—are likely the primary cause of these ...

Department of Medicine III – Hematology/Oncology, LMU University Hospital, LMU Munich, Munich, Germany.

Cancer Research Institute, Seoul National University, Seoul, South Korea.

Jiangsu Breast Disease Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing, PR China.

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. *Corresponding Author: Marc Ladanyi, Department of Pathology and Laboratory Medicine, Memorial ...

Department of Colorectal Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

M. Piffoux and J. Jacquemin contributed equally to this article. O. Tredan and Y. Drouet contributed equally to this article.

Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan. *Corresponding Author: Max S. Wicha, Department of Internal Medicine, University of Michigan–Ann Arbor, 2800 Plymouth Road ...

Abbreviations: BLIA, basal-like immune-activated; BLIS, basal-like immune-suppressed; H&E, hematoxylin and eosin; LumB, luminal B; MES, mesenchymal. Hematoxylin and eosin–stained sections were used to ...